75 related articles for article (PubMed ID: 21982500)
1. Identification of a novel RAMP-independent CGRP receptor antagonist.
Zartman CB; Bell IM; Gallicchio SN; Graham SL; Kane SA; Mallee JJ; Rutledge RZ; Salvatore CA; Vacca JP; Williams TM
Bioorg Med Chem Lett; 2011 Nov; 21(22):6705-8. PubMed ID: 21982500
[TBL] [Abstract][Full Text] [Related]
2. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
[TBL] [Abstract][Full Text] [Related]
4. Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility.
Wood MR; Schirripa KM; Kim JJ; Quigley AG; Stump CA; Bell IM; Bednar RA; Fay JF; Bruno JG; Moore EL; Mosser SD; Roller S; Salvatore CA; Kane SA; Vacca JP; Selnick HG
Bioorg Med Chem Lett; 2009 Oct; 19(19):5787-90. PubMed ID: 19703767
[TBL] [Abstract][Full Text] [Related]
5. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
[TBL] [Abstract][Full Text] [Related]
6. The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists.
Bell IM; Bednar RA; Corcoran HA; Fay JF; Gallicchio SN; Johnston VK; Hershey JC; Miller-Stein CM; Moore EL; Mosser SD; Roller SA; Salvatore CA; Theberge CR; Wong BK; Blair Zartman C; Kane SA; Williams TM; Graham SL; Vacca JP
Bioorg Med Chem Lett; 2009 Aug; 19(16):4740-2. PubMed ID: 19577468
[TBL] [Abstract][Full Text] [Related]
7. Identification of potent, highly constrained CGRP receptor antagonists.
Stump CA; Bell IM; Bednar RA; Fay JF; Gallicchio SN; Hershey JC; Jelley R; Kreatsoulas C; Moore EL; Mosser SD; Quigley AG; Roller SA; Salvatore CA; Sharik SS; Theberge CR; Zartman CB; Kane SA; Graham SL; Selnick HG; Vacca JP; Williams TM
Bioorg Med Chem Lett; 2010 Apr; 20(8):2572-6. PubMed ID: 20299218
[TBL] [Abstract][Full Text] [Related]
8. Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3'5'-monophosphate generation in Eker rat uterine smooth muscle cell line.
Thota C; Yallampalli C
Biol Reprod; 2005 Feb; 72(2):416-22. PubMed ID: 15469997
[TBL] [Abstract][Full Text] [Related]
9. Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
Wai JS; Kim B; Fisher TE; Zhuang L; Embrey MW; Williams PD; Staas DD; Culberson C; Lyle TA; Vacca JP; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Mallai R; Young SD
Bioorg Med Chem Lett; 2007 Oct; 17(20):5595-9. PubMed ID: 17822898
[TBL] [Abstract][Full Text] [Related]
10. MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats.
Bell IM; Stump CA; Gallicchio SN; Staas DD; Zartman CB; Moore EL; Sain N; Urban M; Bruno JG; Calamari A; Kemmerer AL; Mosser SD; Fandozzi C; White RB; Zrada MM; Selnick HG; Graham SL; Vacca JP; Kane SA; Salvatore CA
Bioorg Med Chem Lett; 2012 Jun; 22(12):3941-5. PubMed ID: 22607672
[TBL] [Abstract][Full Text] [Related]
11. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
Rist B; Entzeroth M; Beck-Sickinger AG
J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
Taylor CK; Smith DD; Hulce M; Abel PW
J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
[TBL] [Abstract][Full Text] [Related]
13. RAMPs and CGRP receptors.
Barwell J; Wootten D; Simms J; Hay DL; Poyner DR
Adv Exp Med Biol; 2012; 744():13-24. PubMed ID: 22434104
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonists.
Bell IM; Bednar RA; Fay JF; Gallicchio SN; Hochman JH; McMasters DR; Miller-Stein C; Moore EL; Mosser SD; Pudvah NT; Quigley AG; Salvatore CA; Stump CA; Theberge CR; Wong BK; Zartman CB; Zhang XF; Kane SA; Graham SL; Vacca JP; Williams TM
Bioorg Med Chem Lett; 2006 Dec; 16(24):6165-9. PubMed ID: 17027263
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
Hay DL; Walker CS; Poyner DR
Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
[TBL] [Abstract][Full Text] [Related]
16. Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.
Pace P; Di Francesco ME; Gardelli C; Harper S; Muraglia E; Nizi E; Orvieto F; Petrocchi A; Poma M; Rowley M; Scarpelli R; Laufer R; Gonzalez Paz O; Monteagudo E; Bonelli F; Hazuda D; Stillmock KA; Summa V
J Med Chem; 2007 May; 50(9):2225-39. PubMed ID: 17428043
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide (CGRP) receptor antagonists: pyridine as a replacement for a core amide group.
Luo G; Chen L; Civiello R; Pin SS; Xu C; Kostich W; Kelley M; Conway CM; Macor JE; Dubowchik GM
Bioorg Med Chem Lett; 2012 Apr; 22(8):2917-21. PubMed ID: 22429470
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of adrenomedullin and calcitonin gene-related peptide receptors in vascular smooth muscle cells--effects of receptor activity-modifying protein.
Qi YF; Xue L; Chai SB; Shi YR; Pang YZ; Tang CS
Sheng Li Xue Bao; 2001 Oct; 53(5):396-400. PubMed ID: 11833426
[TBL] [Abstract][Full Text] [Related]
19. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
20. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta.
Yallampalli C; Kondapaka SB; Lanlua P; Wimalawansa SJ; Gangula PR
Biol Reprod; 2004 Apr; 70(4):1055-62. PubMed ID: 14668209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
